Back to Top Skip to main content

Tick Facts: Dangers at the height of tick season

A tick like this one, seen at 10x magnification, can spread a number of dangerous pathogens during the warm-weather months. (Photo by Cornel Constantin) A tick like this one, seen at 10x magnification, can spread a number of dangerous pathogens during the warm-weather months. (Photo by Cornel Constantin)

Recommended Content:

Bug-Borne Illnesses | Bug Week: July 27 - August 2 | Tick-Borne Illnesses | Health Readiness | Preventive Health | Public Health

From April to September, tick activity spikes throughout the United States. With high tick activity comes the importance of increasing awareness of common tick-borne illnesses and how to prevent them.

According to Army Maj. Elizabeth Wanja, of the Uniformed Services University for Health Sciences, outdoor activities during peak tick season raise the chances of transmitting pathogens from living organisms that can carry diseases. These organisms include mosquitos, fleas and, you guessed it, ticks.

“Outdoor activities like farming, camping, and military training exercises in grasslands or edges of the forest increase chances of these pathogens’ transmission,” Wanja said.

Information from the Centers for Disease Control and Prevention states that 77 percent of all insect-borne diseases are carried by ticks. Lyme disease, transmitted through bites from deer ticks, remains the most common of these diseases. However, Lyme is not the only disease to be aware of. Here are five other tick-borne pathogens to be aware of:

Ehrlichiosis, which commonly occurs in the Southeast, South Central, and Midwest U.S., is transmitted to humans primarily by a bite of an infected lone star tick, which is native to this region. Symptoms include fever, chills, headache, muscles aches, and the occasional upset stomach. Ehrlichiosis can be treated in adults and children with the antibiotic Doxycycline.

Anaplasmosis occurs in the Northeast, mid-Atlantic, upper Midwest and West Coast of the U.S. and is transmitted through a bite of the blacklegged tick and the western blacklegged tick. Anaplasmosis has the same symptoms and treatment as ehrlichiosis – the main difference being the tick that carries the disease.

Rocky Mountain spotted fever is caused by infection from a bacterial organism. It is transmitted by a bite of an infected American dog tick, brown dog tick, and the Rocky Mountain wood tick. This is commonly reported in the Southeast U.S. This infection causes high fever, headache, and rash, and can be deadly if not treated with Doxycycline.

Powassan virus is a rare, tick-borne flavivirus that can have severe effects on the human nervous system. The deer tick transmits Powassan, which is a rare infection that’s on the rise, with 33 cases in 2017 alone. There are currently no vaccines or treatments for Powassan virus infection, so hospitalization is imperative to help with breathing complications and brain swelling.

The most peculiar tick-borne disease on the list, alpha-gal syndrome, occurs when the alpha-gal sugar molecule – often found in red meats like beef and pork – is transmitted into the human body. This molecule has been associated with the bite of the lone star tick, transmitted through saliva. Studies are still ongoing to find a specific link between alpha-gal syndrome and ticks, but the result for a human can be a tick-caused red meat allergy.

Tick-borne illnesses can also be transported overseas. U.S. military personnel and their family members deploy to various regions of the world, where they can be exposed to arthropod-borne diseases that the rest of the U.S. population does not encounter.

“These deployments expose service members and families to novel pathogens which may be introduced in the U.S. when infected personnel redeploy back home,” Wanja said.

Luckily, there are various ways to reduce the chances of getting tick-borne infections. They include avoiding areas where ticks may be found and checking for ticks if someone conducts activities that might bring them into tick-prone areas.

Use of skin-topical repellents and treated clothing, wearing of pants tucked in shoes and boots, and proper removal of ticks to avoid pathogens being injected into the body can also prevent the spread of these illnesses.

For more prevention tips and ways to identify different bugs and bites, visit the Military Health System’s Bug Week page.

You also may be interested in...

DHA IPM 19-006: 2019–2020 Seasonal Influenza Vaccination Program (IVP)

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (o), implementing instructions, assigns responsibilities, and prescribes procedures for the seasonal influenza vaccination program. • This DHA-IPM cancels and reissues DHA-IPM 18-005. • This DHA-IPM is effective immediately and will expire 12 months from the date of issue.

DHA IPM 19-003: Reserve Health Readiness Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (i): • Provides utilization guidance and funding requirements for the RHRP contract to supplement Reserve Component Individual Medical Readiness (IMR) and Deployment Health activities when Service organic health readiness resources are not available to meet mission requirements. • Provides utilization guidance and funding requirements for the RHRP contract for Active Duty enrolled in TRICARE Prime Remote, U.S. Coast Guard (USCG), USCG Reserves, and re-deploying DoD civilians (e.g., U.S. Army Corps of Engineers and U.S. Army Intelligence and Security Command). • Communicate procedure guidance to all DoD organizations utilizing RHRP services. • Will expire effective 12 months from the date of issue and be converted to a DHA-Procedural Instruction.

  • Identification #: 19-003
  • Date: 3/8/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Health Readiness

DHA PI 6025.07: Naloxone in the MTFs

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

DHA PI 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z). This DHA-PI applies to: a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”). b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.

  • Identification #: DHA PI 6200.05
  • Date: 5/2/2018
  • Type: DHA Procedural Instruction
  • Topics: Health Readiness

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Policy

Guidance as of 17 OCT 2014 from the Department of Defese (AFHSC)for Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

DoD Instruction 1010.10: Health Promotion and Disease Prevention

Policy

This instruction reissues DoD Directive (DoDD) 1010.10 (Reference (a)) as a DoD instruction (DoDI) in accordance with the authority in DoDD 5124.02 (Reference (b)) to establish policy and assign responsibilities for health promotion and disease prevention in accordance with References (c) through (f).

  • Identification #: DoD Instruction 1010.10
  • Date: 4/28/2014
  • Type: Instructions
  • Topics: Preventive Health

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

DoD Laboratories Participating in CDC Laboratory Response Network 03-213

Policy

Department of Defense (DoD) laboratories participating in the Centers for Disease Control and Prevention-sponsored Laboratory Response Network (LRN) do so with the approval and support of their respective Military Department Surgeons General.

Medical Planning and Programming Lexicon

Policy

DoD Instruction Number 6490.11: DoD Policy Guidance for Management of Mild Traumatic Brain Injury/Concussion in the Deployed Setting

Policy

This instruction establishes policy, assigns responsibilities, and provides procedures on the management of mild traumatic brain injury (mTBI), also known as concussion, in the deployed setting.

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy
<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.